Prolonged treatment-free remission in chronic myeloid leukemia patients with previous BCR-ABL1 kinase domain mutations

• Simone Claudiani,
• Jane F. Apperley,
• Afzal Khan,
• Jamshid Khorashad,
• Dragana Milojkovic

Affiliations

Simone Claudiani

Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London;Centre for Haematology, Department of Immunity and Inflammation, Faculty of Medicine, Imperial College London at Hammersmith Hospital, London, UK

Jane F. Apperley

Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London;Centre for Haematology, Department of Immunity and Inflammation, Faculty of Medicine, Imperial College London at Hammersmith Hospital, London, UK

Afzal Khan

Centre for Haematology, Department of Immunity and Inflammation, Faculty of Medicine, Imperial College London at Hammersmith Hospital, London, UK

Jamshid Khorashad

Centre for Haematology, Department of Immunity and Inflammation, Faculty of Medicine, Imperial College London at Hammersmith Hospital, London, UK

Dragana Milojkovic

Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London